Matches in Wikidata for { <http://www.wikidata.org/entity/Q90463295> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90463295 description "article scientifique publié en 2020" @default.
- Q90463295 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90463295 description "scientific article published on 19 March 2020" @default.
- Q90463295 description "wetenschappelijk artikel" @default.
- Q90463295 description "наукова стаття, опублікована 19 березня 2020" @default.
- Q90463295 name "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 name "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 type Item @default.
- Q90463295 label "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 label "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 prefLabel "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 prefLabel "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 P1433 Q90463295-D31FF44D-7DE2-4EF6-88C7-A95E5B70DE38 @default.
- Q90463295 P1476 Q90463295-B3C11764-B1DF-4FB2-86F6-5B9A323AD3F1 @default.
- Q90463295 P2093 Q90463295-2D4E8BD9-74E3-4149-A98F-04E0AC102036 @default.
- Q90463295 P2093 Q90463295-40E625B0-2E29-424C-83B1-52ECB9855D13 @default.
- Q90463295 P2093 Q90463295-B8D987C0-941D-42AC-940C-158899C13003 @default.
- Q90463295 P31 Q90463295-C1312DBB-5A49-44F8-8ED0-642A80B648C2 @default.
- Q90463295 P356 Q90463295-C32765A6-B77D-44B6-8BE1-2C4D7DBCB16B @default.
- Q90463295 P577 Q90463295-9FAA0A41-69B2-4C70-842C-ED0A839832C1 @default.
- Q90463295 P698 Q90463295-4552A770-F8BE-4E23-B1CE-19336D3CA672 @default.
- Q90463295 P921 Q90463295-4EE3F826-9F4E-4148-9815-D9210A24A80D @default.
- Q90463295 P921 Q90463295-587E5CC8-F8C4-488D-93EC-87AD75A30725 @default.
- Q90463295 P921 Q90463295-AA368C81-8450-472A-A811-484393C84A21 @default.
- Q90463295 P356 S0031-0808.20.03869-0 @default.
- Q90463295 P698 32192324 @default.
- Q90463295 P1433 Q27712548 @default.
- Q90463295 P1476 "Therapeutic effect of bevacizumab combined with chemotherapy in patients with platinum-resistant ovarian cancer and its effect on vascular cell adhesion molecule 1 and FBXW7" @default.
- Q90463295 P2093 "Xiaomei Liu" @default.
- Q90463295 P2093 "Xue Pan" @default.
- Q90463295 P2093 "Zhenhua Du" @default.
- Q90463295 P31 Q13442814 @default.
- Q90463295 P356 "10.23736/S0031-0808.20.03869-0" @default.
- Q90463295 P577 "2020-03-19T00:00:00Z" @default.
- Q90463295 P698 "32192324" @default.
- Q90463295 P921 Q172341 @default.
- Q90463295 P921 Q187640 @default.
- Q90463295 P921 Q413299 @default.